Balanced IV solutions may benefit critically ill patients
Editor's Note
Using balanced solutions in intravenous fluid (IV) therapy instead of saline can reduce the risk of death in critically ill patients in intensive care by 4%. These findings were published by The Lancet Respiratory Medicine on November 30.
Patients in intensive care typically receive IV fluids, which can be made up of saline or balanced crystalloids, which in turn are more aligned with the chemistry of human blood. For this study, researchers looked at data from 34,685 patients across six clinical trials conducted in the US, Australia, New Zealand, and Brazil.
They found that a patient’s odds of dying was reduced by 4% when given balanced solutions. The researchers note that in a small subset of patients with traumatic brain injury, however, the risk of death was higher with balanced solutions (19.1%) versus saline (14.7%).
The findings revealed that balanced IV solutions may be a better treatment choice for most intensive care patients and can help inform clinician decision-making.
Free Daily News
- FDA medical device class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery
- AAMI guidance covers sterile processing of dilators, ultrasound probes
- Surgical site infections often caused by preexisting bacteria
- The Joint Commission launches new telehealth accreditation program
- FDA announces class 1 recall for disposable biopsy needle kit
- Report: Consistent, purposeful manager-team engagement reduces RN turnover
- Death, hospital readmission less likely for women treated by female doctors
- FDA announces class 1 recalls for infusion pumps, anesthesia workstation
- Study finds workforce readiness gap in new nurses